The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...
Analysts are out in force on Netflix, with shares sliding after the streaming service posted its slowest revenue growth rate ...
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
The Christian Post on MSN
5 notable reactions to violent riots roiling France: 'They're destroying that country'
Here are five notable reactions to the chaos in France, which some see as part of a wider assault against a teetering ...
Rising crude oil prices do not necessarily end with just an increase in energy costs. They can ripple into prices through ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced several updated poster presentations at MSToronto2026, the 10th Joint ...
Catalysts spur chemical reactions used across industries, from producing fuels and medicines to manufacturing chemicals and ...
If anything, it might be slightly worse than expected. Leading the inflationary economic data-pack, the U.S. Bureau of Labor ...
More than 275 new complaints have been filed over Millie Moon diapers in the past month, with parents describing burns and ...
UNLOXCYT receives NCCN Category 2A Preferred Designation for laCSCC patients ineligible for surgery or radiation. The ...
The Fed's rate hike decisions and market reactions are analyzed, with a look at what might be driving their strategy.
Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results